MedTrace Logo

Cavernous Tissue Preservation During Penile Prosthesis Implantation

NCT03733860 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-11-08

No results posted yet for this study

Summary

Spontaneous penile tumescence after penile prosthesis implantation has been previously reported as sporadically occurring during implant surgery. This study aims at systematically preserving residual erectile function, by the preservation of the patients' spontaneous penile tumescence by systematically sparing cavernous tissue during penile prosthesis implantation.

Conditions

Interventions

PROCEDURE

Cavernous tissue sparing penile prosthesis implantation

Beginning penile prosthesis implantation (Coloplast Titan USA) procedure after intracavenosal injection of PGE1 prostine.

PROCEDURE

Conventional penile prosthesis implantation

Beginning penile implant procedure (Coloplast Titan USA) without prior intracavernosal injection of PGE1 prostine

PROCEDURE

Intracavernosal injection of alprostadil

Intraoperative intracavernosal injection of alprostadil in the cavernous sparing group

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Adham Zaazaa, PhD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
81 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2018-12-31
Completion
2018-12-31
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03733860 on ClinicalTrials.gov